United Therapeutics CFO executes 10b5-1 sale after option exercise
Rhea-AI Filing Summary
United Therapeutics (UTHR) reported an insider transaction by its CFO and Treasurer. On 11/10/2025, the officer exercised 21,000 stock options at $146.03 and sold the resulting shares in multiple tranches at weighted average prices ranging from $445.81 to $456.27, as detailed in the trade notes. Following these transactions, the officer beneficially owned 8,118 shares directly. The activity was conducted under a Rule 10b5-1 trading plan entered on August 5, 2025.
In addition, the filing shows 10,312 stock options beneficially owned after the reported transactions, with the exercised grant originally exercisable from March 15, 2020 and expiring March 15, 2027.
Positive
- None.
Negative
- None.
Insights
Administrative Form 4: option exercise with planned sales.
The CFO exercised $146.03 strike options for 21,000 shares and sold shares across multiple weighted-average prices between $445.81 and $456.27. The trades were executed pursuant to a Rule 10b5-1 plan, indicating pre-arranged instructions.
Post-transaction, direct common stock ownership is 8,118 shares, and derivative holdings include 10,312 stock options. This reflects routine equity compensation activity rather than a change in business fundamentals.
The filing lists specific price ranges per tranche; actual market impact depends on daily liquidity and trade size relative to average volume. Subsequent filings may provide additional context on future vesting or exercises.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 21,000 | $0.00 | -- |
| Exercise | Common Stock | 21,000 | $146.03 | $3.07M |
| Sale | Common Stock | 1,052 | $446.5087 | $470K |
| Sale | Common Stock | 1,539 | $447.4691 | $689K |
| Sale | Common Stock | 3,356 | $448.3298 | $1.50M |
| Sale | Common Stock | 653 | $449.0006 | $293K |
| Sale | Common Stock | 600 | $450.7996 | $270K |
| Sale | Common Stock | 1,065 | $451.869 | $481K |
| Sale | Common Stock | 2,170 | $452.7554 | $982K |
| Sale | Common Stock | 4,633 | $453.8134 | $2.10M |
| Sale | Common Stock | 3,342 | $454.8156 | $1.52M |
| Sale | Common Stock | 2,590 | $455.8295 | $1.18M |
Footnotes (1)
- This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 5, 2025. This transaction was executed in multiple trades at prices ranging from $455.35 to $456.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $445.81 to $446.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $446.81 to $447.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $448.82 to $449.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $450.24 to $451.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $451.31 to $452.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $452.32 to $453.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $453.34 to $454.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $454.35 to $455.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
